Overview
ALG Pharma is a Polish producer, distributor, and exporter of dietary supplements. Its range includes electrolytes, products for immune support, respiratory support, lecithin, and breath-freshening products. The company also offers supplements for athletes, vitamins, minerals, and products supporting the digestive system, liver, and memory.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-07-07. Active
33 1140 2062 0000 2478 6400 2001
Bank spółdzielczy12 9288 0001 5599 1092 2000 0040- Bank spółdzielczy20 9288 0001 5599 1092 2000 0090
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
27 public aid cases recorded, with a total value of $1,899,355.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $10,464 | Lubelska Fundacja Rozwoju | |
| Aug 5, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $116,524 | Prezes Banku Gospodarstwa Krajowego | |
| Dec 11, 2024 | Regional investment aid | $899,756 | Marszałek Województwa Mazowieckiego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | Realizacja prac B+R nad opracowaniem innowacyjnych form suplementów diety wraz z wdrożeniem. | $1,375,004 | Fundusze Europejskie dla Mazowsza 2021-2027 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board is authorised to make declarations concerning the company’s property and non-property rights and obligations and to sign on behalf of the company independently. In the case of a multi-member management board, two members of the management board acting jointly are authorised to make declarations of will on behalf of the company and to represent it.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tomasz Jakub Batycki (43) | 350 | $4,727.17 | 35% |
Piotr Jamróz (40) | 350 | $4,727.17 | 35% |
Anna Barbara Korczak (46) | 300 | $4,051.86 | 30% |
Beneficial owners
| Person | Rights |
|---|---|
Tomasz Jakub Batycki (43)  | Shareholder of a limited liability company, 17500.0 PLN |
Piotr Jamróz (40) | Shareholder of a limited liability company, 17500.0 PLN |
Anna Barbara Korczak (46) | Shareholder of a limited liability company, 15000.0 PLN |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Promar Przedsiębiorstwo Produkcyjno Handlowesp. z o.o. | $46,457,960.73 | promar.pl | |
| Zakłady Farmaceutyczne ColfarmS.A. | $27,692,749.78 | colfarm.pl | |
| AKOS.A. | $25,706,868.29 | ako.com.pl | |
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | |
| Master PharmS.A. | $23,116,954.19 | masterpharm.pl | |
| Belfoodsp. z o.o. | $21,408,270.58 | belfood.pl | |
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | |
| Premium Rosasp. z o.o. | $10,653,161.35 | premiumrosa.eu | |
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | |
| Yangosp. z o.o. | $8,214,312.60 | yango.pl |
Change history
| Date | Event |
|---|---|
| 2025-10-14 | PKD change (Removed: 10.89.Z; Added: 10.89.A) |
| 2021-12-31 | Entered in the register |
FAQ
Last updated: 2026-05-22